Global Latanoprost Market

Latanoprost Comprehensive Study by Type (Brand Drug, Generic Drug), Application (Open-angle Glaucoma, Close-angle Glaucoma), End Users (Pediatrics, Adults, Geriatrics), Bottle Size (2.5 ml, 5 ml, Others) Players and Region - Global Market Outlook to 2030

Latanoprost Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 2.4%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Latanoprost Market Scope?
The latanoprost eye drop is used to treat certain kinds of glaucoma. It is also used to treat a condition called hypertension of the eye alone or together with other medicines to lower pressure inside the eye that is caused by open-angle glaucoma or ocular (eye) hypertension. Latanoprost appears to work by increasing the outflow of fluid from the eye. This lowers the pressure in the eye. It belongs to a group of medicines called prostaglandins. The rising prevalence of glaucoma diseases is one of the major factors driving the growth of the market.

Influencing Trend:
Technological Improvement

Market Growth Drivers:
The Rising Prevalence of Glaucoma Diseases, Increasing Geriatric Population Worldwide and Growing Hypertension Prevalence among the People

Challenges:
The pricing and reimbursement negotiations can vary widely, impacting the affordability and accessibility of Latanoprost for patients in different countries

Restraints:
Several Adverse Effects Such As Darkening Of the Periocular Skin by the Use of Latanoprost and Latanoprost Tends To Be Less Effective In Lowering IOP in Children than In Adults

Opportunities:
Research and Developments Activities Coupled with Drug Pipeline and Emerging Demand from Developing Regions

The Latanoprost market study is being classified by Type (Brand Drug and Generic Drug), by Application and major geographies with country level break-up. According to AMA, the Global Latanoprost market is expected to see growth rate of 2.4% and may see market size of USD1.42 Billion by 2030.

Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Latanoprost market throughout the predicted period.

Pfizer (United States), Aerie Pharmaceuticals (United States), Mylan (United States), Novartis International AG (Switzerland), Teva Pharmaceutical Industries (Israel), S.C. ROMPHARM COMPANY S.R.L (Romania), Apotex (Canada), Sun Pharma (India) and CR Zizhu (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Laboratoire Riva (Canada), Taj Pharma (India), Sandoz (Germany) and Laboratoires Thea (France).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Latanoprost market by Type, Application and Region.

On the basis of geography, the market of Latanoprost has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In March 2019, Aerie Pharmaceuticals Announced U.S. FDA Approval of Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the Reduction of Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension.
In September 2018, Sun Pharma and SPARC Announce US FDA Approval of XELPROS to Treat Open-angle Glaucoma or Ocular Hypertension. XELPROS (latanoprost ophthalmic emulsion) 0.005% for topical ophthalmic use is the first and only benzalkonium chloride-free (BAK-free) form of latanoprost.
The March 2011, approval of generic latanoprost by the U.S. Food and Drug Administration and the consequent availability over generic latanoprost in other countries has significantly reduced the cost associated with the use of this drug and has made it a very practical option for reducing intraocular pressure in glaucoma and ocular hypertension patients in developing countries.

Key Target Audience
Latonoprost Manufacturers, Latonoprost Traders/Distributors, Latonoprost Importer/Exporter, Regulatory & Government Bodies, Research Institutes, Downstream Vendors, End Users and Others

Latanoprost Market Study: Important Years
AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Billion)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Latanoprost Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Latanoprost industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Brand Drug
  • Generic Drug
By Application
  • Open-angle Glaucoma
  • Close-angle Glaucoma
By End Users
  • Pediatrics
  • Adults
  • Geriatrics

By Bottle Size
  • 2.5 ml
  • 5 ml
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Prevalence of Glaucoma Diseases
      • 3.2.2. Increasing Geriatric Population Worldwide
      • 3.2.3. Growing Hypertension Prevalence among the People
    • 3.3. Market Challenges
      • 3.3.1. The pricing and reimbursement negotiations can vary widely, impacting the affordability and accessibility of Latanoprost for patients in different countries
    • 3.4. Market Trends
      • 3.4.1. Technological Improvement
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Latanoprost, by Type, Application, End Users, Bottle Size and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Latanoprost (Value)
      • 5.2.1. Global Latanoprost by: Type (Value)
        • 5.2.1.1. Brand Drug
        • 5.2.1.2. Generic Drug
      • 5.2.2. Global Latanoprost by: Application (Value)
        • 5.2.2.1. Open-angle Glaucoma
        • 5.2.2.2. Close-angle Glaucoma
      • 5.2.3. Global Latanoprost by: End Users (Value)
        • 5.2.3.1. Pediatrics
        • 5.2.3.2. Adults
        • 5.2.3.3. Geriatrics
      • 5.2.4. Global Latanoprost by: Bottle Size (Value)
        • 5.2.4.1. 2.5 ml
        • 5.2.4.2. 5 ml
        • 5.2.4.3. Others
      • 5.2.5. Global Latanoprost Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Latanoprost (Volume)
      • 5.3.1. Global Latanoprost by: Type (Volume)
        • 5.3.1.1. Brand Drug
        • 5.3.1.2. Generic Drug
      • 5.3.2. Global Latanoprost by: Application (Volume)
        • 5.3.2.1. Open-angle Glaucoma
        • 5.3.2.2. Close-angle Glaucoma
      • 5.3.3. Global Latanoprost by: End Users (Volume)
        • 5.3.3.1. Pediatrics
        • 5.3.3.2. Adults
        • 5.3.3.3. Geriatrics
      • 5.3.4. Global Latanoprost by: Bottle Size (Volume)
        • 5.3.4.1. 2.5 ml
        • 5.3.4.2. 5 ml
        • 5.3.4.3. Others
      • 5.3.5. Global Latanoprost Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Latanoprost (Price)
      • 5.4.1. Global Latanoprost by: Type (Price)
  • 6. Latanoprost: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aerie Pharmaceuticals (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Mylan (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis International AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Teva Pharmaceutical Industries (Israel)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. S.C. ROMPHARM COMPANY S.R.L (Romania)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Apotex (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sun Pharma (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CR Zizhu (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Latanoprost Sale, by Type, Application, End Users, Bottle Size and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Latanoprost (Value)
      • 7.2.1. Global Latanoprost by: Type (Value)
        • 7.2.1.1. Brand Drug
        • 7.2.1.2. Generic Drug
      • 7.2.2. Global Latanoprost by: Application (Value)
        • 7.2.2.1. Open-angle Glaucoma
        • 7.2.2.2. Close-angle Glaucoma
      • 7.2.3. Global Latanoprost by: End Users (Value)
        • 7.2.3.1. Pediatrics
        • 7.2.3.2. Adults
        • 7.2.3.3. Geriatrics
      • 7.2.4. Global Latanoprost by: Bottle Size (Value)
        • 7.2.4.1. 2.5 ml
        • 7.2.4.2. 5 ml
        • 7.2.4.3. Others
      • 7.2.5. Global Latanoprost Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Latanoprost (Volume)
      • 7.3.1. Global Latanoprost by: Type (Volume)
        • 7.3.1.1. Brand Drug
        • 7.3.1.2. Generic Drug
      • 7.3.2. Global Latanoprost by: Application (Volume)
        • 7.3.2.1. Open-angle Glaucoma
        • 7.3.2.2. Close-angle Glaucoma
      • 7.3.3. Global Latanoprost by: End Users (Volume)
        • 7.3.3.1. Pediatrics
        • 7.3.3.2. Adults
        • 7.3.3.3. Geriatrics
      • 7.3.4. Global Latanoprost by: Bottle Size (Volume)
        • 7.3.4.1. 2.5 ml
        • 7.3.4.2. 5 ml
        • 7.3.4.3. Others
      • 7.3.5. Global Latanoprost Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Latanoprost (Price)
      • 7.4.1. Global Latanoprost by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Latanoprost: by Type(USD Billion)
  • Table 2. Latanoprost Brand Drug , by Region USD Billion (2018-2023)
  • Table 3. Latanoprost Generic Drug , by Region USD Billion (2018-2023)
  • Table 4. Latanoprost: by Application(USD Billion)
  • Table 5. Latanoprost Open-angle Glaucoma , by Region USD Billion (2018-2023)
  • Table 6. Latanoprost Close-angle Glaucoma , by Region USD Billion (2018-2023)
  • Table 7. Latanoprost: by End Users(USD Billion)
  • Table 8. Latanoprost Pediatrics , by Region USD Billion (2018-2023)
  • Table 9. Latanoprost Adults , by Region USD Billion (2018-2023)
  • Table 10. Latanoprost Geriatrics , by Region USD Billion (2018-2023)
  • Table 11. Latanoprost: by Bottle Size(USD Billion)
  • Table 12. Latanoprost 2.5 ml , by Region USD Billion (2018-2023)
  • Table 13. Latanoprost 5 ml , by Region USD Billion (2018-2023)
  • Table 14. Latanoprost Others , by Region USD Billion (2018-2023)
  • Table 15. South America Latanoprost, by Country USD Billion (2018-2023)
  • Table 16. South America Latanoprost, by Type USD Billion (2018-2023)
  • Table 17. South America Latanoprost, by Application USD Billion (2018-2023)
  • Table 18. South America Latanoprost, by End Users USD Billion (2018-2023)
  • Table 19. South America Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 20. Brazil Latanoprost, by Type USD Billion (2018-2023)
  • Table 21. Brazil Latanoprost, by Application USD Billion (2018-2023)
  • Table 22. Brazil Latanoprost, by End Users USD Billion (2018-2023)
  • Table 23. Brazil Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 24. Argentina Latanoprost, by Type USD Billion (2018-2023)
  • Table 25. Argentina Latanoprost, by Application USD Billion (2018-2023)
  • Table 26. Argentina Latanoprost, by End Users USD Billion (2018-2023)
  • Table 27. Argentina Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 28. Rest of South America Latanoprost, by Type USD Billion (2018-2023)
  • Table 29. Rest of South America Latanoprost, by Application USD Billion (2018-2023)
  • Table 30. Rest of South America Latanoprost, by End Users USD Billion (2018-2023)
  • Table 31. Rest of South America Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 32. Asia Pacific Latanoprost, by Country USD Billion (2018-2023)
  • Table 33. Asia Pacific Latanoprost, by Type USD Billion (2018-2023)
  • Table 34. Asia Pacific Latanoprost, by Application USD Billion (2018-2023)
  • Table 35. Asia Pacific Latanoprost, by End Users USD Billion (2018-2023)
  • Table 36. Asia Pacific Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 37. China Latanoprost, by Type USD Billion (2018-2023)
  • Table 38. China Latanoprost, by Application USD Billion (2018-2023)
  • Table 39. China Latanoprost, by End Users USD Billion (2018-2023)
  • Table 40. China Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 41. Japan Latanoprost, by Type USD Billion (2018-2023)
  • Table 42. Japan Latanoprost, by Application USD Billion (2018-2023)
  • Table 43. Japan Latanoprost, by End Users USD Billion (2018-2023)
  • Table 44. Japan Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 45. India Latanoprost, by Type USD Billion (2018-2023)
  • Table 46. India Latanoprost, by Application USD Billion (2018-2023)
  • Table 47. India Latanoprost, by End Users USD Billion (2018-2023)
  • Table 48. India Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 49. South Korea Latanoprost, by Type USD Billion (2018-2023)
  • Table 50. South Korea Latanoprost, by Application USD Billion (2018-2023)
  • Table 51. South Korea Latanoprost, by End Users USD Billion (2018-2023)
  • Table 52. South Korea Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 53. Taiwan Latanoprost, by Type USD Billion (2018-2023)
  • Table 54. Taiwan Latanoprost, by Application USD Billion (2018-2023)
  • Table 55. Taiwan Latanoprost, by End Users USD Billion (2018-2023)
  • Table 56. Taiwan Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 57. Australia Latanoprost, by Type USD Billion (2018-2023)
  • Table 58. Australia Latanoprost, by Application USD Billion (2018-2023)
  • Table 59. Australia Latanoprost, by End Users USD Billion (2018-2023)
  • Table 60. Australia Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 61. Rest of Asia-Pacific Latanoprost, by Type USD Billion (2018-2023)
  • Table 62. Rest of Asia-Pacific Latanoprost, by Application USD Billion (2018-2023)
  • Table 63. Rest of Asia-Pacific Latanoprost, by End Users USD Billion (2018-2023)
  • Table 64. Rest of Asia-Pacific Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 65. Europe Latanoprost, by Country USD Billion (2018-2023)
  • Table 66. Europe Latanoprost, by Type USD Billion (2018-2023)
  • Table 67. Europe Latanoprost, by Application USD Billion (2018-2023)
  • Table 68. Europe Latanoprost, by End Users USD Billion (2018-2023)
  • Table 69. Europe Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 70. Germany Latanoprost, by Type USD Billion (2018-2023)
  • Table 71. Germany Latanoprost, by Application USD Billion (2018-2023)
  • Table 72. Germany Latanoprost, by End Users USD Billion (2018-2023)
  • Table 73. Germany Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 74. France Latanoprost, by Type USD Billion (2018-2023)
  • Table 75. France Latanoprost, by Application USD Billion (2018-2023)
  • Table 76. France Latanoprost, by End Users USD Billion (2018-2023)
  • Table 77. France Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 78. Italy Latanoprost, by Type USD Billion (2018-2023)
  • Table 79. Italy Latanoprost, by Application USD Billion (2018-2023)
  • Table 80. Italy Latanoprost, by End Users USD Billion (2018-2023)
  • Table 81. Italy Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 82. United Kingdom Latanoprost, by Type USD Billion (2018-2023)
  • Table 83. United Kingdom Latanoprost, by Application USD Billion (2018-2023)
  • Table 84. United Kingdom Latanoprost, by End Users USD Billion (2018-2023)
  • Table 85. United Kingdom Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 86. Netherlands Latanoprost, by Type USD Billion (2018-2023)
  • Table 87. Netherlands Latanoprost, by Application USD Billion (2018-2023)
  • Table 88. Netherlands Latanoprost, by End Users USD Billion (2018-2023)
  • Table 89. Netherlands Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 90. Rest of Europe Latanoprost, by Type USD Billion (2018-2023)
  • Table 91. Rest of Europe Latanoprost, by Application USD Billion (2018-2023)
  • Table 92. Rest of Europe Latanoprost, by End Users USD Billion (2018-2023)
  • Table 93. Rest of Europe Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 94. MEA Latanoprost, by Country USD Billion (2018-2023)
  • Table 95. MEA Latanoprost, by Type USD Billion (2018-2023)
  • Table 96. MEA Latanoprost, by Application USD Billion (2018-2023)
  • Table 97. MEA Latanoprost, by End Users USD Billion (2018-2023)
  • Table 98. MEA Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 99. Middle East Latanoprost, by Type USD Billion (2018-2023)
  • Table 100. Middle East Latanoprost, by Application USD Billion (2018-2023)
  • Table 101. Middle East Latanoprost, by End Users USD Billion (2018-2023)
  • Table 102. Middle East Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 103. Africa Latanoprost, by Type USD Billion (2018-2023)
  • Table 104. Africa Latanoprost, by Application USD Billion (2018-2023)
  • Table 105. Africa Latanoprost, by End Users USD Billion (2018-2023)
  • Table 106. Africa Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 107. North America Latanoprost, by Country USD Billion (2018-2023)
  • Table 108. North America Latanoprost, by Type USD Billion (2018-2023)
  • Table 109. North America Latanoprost, by Application USD Billion (2018-2023)
  • Table 110. North America Latanoprost, by End Users USD Billion (2018-2023)
  • Table 111. North America Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 112. United States Latanoprost, by Type USD Billion (2018-2023)
  • Table 113. United States Latanoprost, by Application USD Billion (2018-2023)
  • Table 114. United States Latanoprost, by End Users USD Billion (2018-2023)
  • Table 115. United States Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 116. Canada Latanoprost, by Type USD Billion (2018-2023)
  • Table 117. Canada Latanoprost, by Application USD Billion (2018-2023)
  • Table 118. Canada Latanoprost, by End Users USD Billion (2018-2023)
  • Table 119. Canada Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 120. Mexico Latanoprost, by Type USD Billion (2018-2023)
  • Table 121. Mexico Latanoprost, by Application USD Billion (2018-2023)
  • Table 122. Mexico Latanoprost, by End Users USD Billion (2018-2023)
  • Table 123. Mexico Latanoprost, by Bottle Size USD Billion (2018-2023)
  • Table 124. Latanoprost Sales: by Type(K Liters)
  • Table 125. Latanoprost Sales Brand Drug , by Region K Liters (2018-2023)
  • Table 126. Latanoprost Sales Generic Drug , by Region K Liters (2018-2023)
  • Table 127. Latanoprost Sales: by Application(K Liters)
  • Table 128. Latanoprost Sales Open-angle Glaucoma , by Region K Liters (2018-2023)
  • Table 129. Latanoprost Sales Close-angle Glaucoma , by Region K Liters (2018-2023)
  • Table 130. Latanoprost Sales: by End Users(K Liters)
  • Table 131. Latanoprost Sales Pediatrics , by Region K Liters (2018-2023)
  • Table 132. Latanoprost Sales Adults , by Region K Liters (2018-2023)
  • Table 133. Latanoprost Sales Geriatrics , by Region K Liters (2018-2023)
  • Table 134. Latanoprost Sales: by Bottle Size(K Liters)
  • Table 135. Latanoprost Sales 2.5 ml , by Region K Liters (2018-2023)
  • Table 136. Latanoprost Sales 5 ml , by Region K Liters (2018-2023)
  • Table 137. Latanoprost Sales Others , by Region K Liters (2018-2023)
  • Table 138. South America Latanoprost Sales, by Country K Liters (2018-2023)
  • Table 139. South America Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 140. South America Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 141. South America Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 142. South America Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 143. Brazil Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 144. Brazil Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 145. Brazil Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 146. Brazil Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 147. Argentina Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 148. Argentina Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 149. Argentina Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 150. Argentina Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 151. Rest of South America Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 152. Rest of South America Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 153. Rest of South America Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 154. Rest of South America Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 155. Asia Pacific Latanoprost Sales, by Country K Liters (2018-2023)
  • Table 156. Asia Pacific Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 157. Asia Pacific Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 158. Asia Pacific Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 159. Asia Pacific Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 160. China Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 161. China Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 162. China Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 163. China Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 164. Japan Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 165. Japan Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 166. Japan Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 167. Japan Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 168. India Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 169. India Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 170. India Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 171. India Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 172. South Korea Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 173. South Korea Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 174. South Korea Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 175. South Korea Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 176. Taiwan Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 177. Taiwan Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 178. Taiwan Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 179. Taiwan Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 180. Australia Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 181. Australia Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 182. Australia Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 183. Australia Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 184. Rest of Asia-Pacific Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 185. Rest of Asia-Pacific Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 186. Rest of Asia-Pacific Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 187. Rest of Asia-Pacific Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 188. Europe Latanoprost Sales, by Country K Liters (2018-2023)
  • Table 189. Europe Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 190. Europe Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 191. Europe Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 192. Europe Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 193. Germany Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 194. Germany Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 195. Germany Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 196. Germany Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 197. France Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 198. France Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 199. France Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 200. France Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 201. Italy Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 202. Italy Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 203. Italy Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 204. Italy Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 205. United Kingdom Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 206. United Kingdom Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 207. United Kingdom Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 208. United Kingdom Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 209. Netherlands Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 210. Netherlands Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 211. Netherlands Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 212. Netherlands Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 213. Rest of Europe Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 214. Rest of Europe Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 215. Rest of Europe Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 216. Rest of Europe Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 217. MEA Latanoprost Sales, by Country K Liters (2018-2023)
  • Table 218. MEA Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 219. MEA Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 220. MEA Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 221. MEA Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 222. Middle East Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 223. Middle East Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 224. Middle East Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 225. Middle East Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 226. Africa Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 227. Africa Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 228. Africa Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 229. Africa Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 230. North America Latanoprost Sales, by Country K Liters (2018-2023)
  • Table 231. North America Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 232. North America Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 233. North America Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 234. North America Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 235. United States Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 236. United States Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 237. United States Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 238. United States Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 239. Canada Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 240. Canada Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 241. Canada Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 242. Canada Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 243. Mexico Latanoprost Sales, by Type K Liters (2018-2023)
  • Table 244. Mexico Latanoprost Sales, by Application K Liters (2018-2023)
  • Table 245. Mexico Latanoprost Sales, by End Users K Liters (2018-2023)
  • Table 246. Mexico Latanoprost Sales, by Bottle Size K Liters (2018-2023)
  • Table 247. Latanoprost: by Type(USD/Units)
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Latanoprost: by Type(USD Billion)
  • Table 258. Latanoprost Brand Drug , by Region USD Billion (2025-2030)
  • Table 259. Latanoprost Generic Drug , by Region USD Billion (2025-2030)
  • Table 260. Latanoprost: by Application(USD Billion)
  • Table 261. Latanoprost Open-angle Glaucoma , by Region USD Billion (2025-2030)
  • Table 262. Latanoprost Close-angle Glaucoma , by Region USD Billion (2025-2030)
  • Table 263. Latanoprost: by End Users(USD Billion)
  • Table 264. Latanoprost Pediatrics , by Region USD Billion (2025-2030)
  • Table 265. Latanoprost Adults , by Region USD Billion (2025-2030)
  • Table 266. Latanoprost Geriatrics , by Region USD Billion (2025-2030)
  • Table 267. Latanoprost: by Bottle Size(USD Billion)
  • Table 268. Latanoprost 2.5 ml , by Region USD Billion (2025-2030)
  • Table 269. Latanoprost 5 ml , by Region USD Billion (2025-2030)
  • Table 270. Latanoprost Others , by Region USD Billion (2025-2030)
  • Table 271. South America Latanoprost, by Country USD Billion (2025-2030)
  • Table 272. South America Latanoprost, by Type USD Billion (2025-2030)
  • Table 273. South America Latanoprost, by Application USD Billion (2025-2030)
  • Table 274. South America Latanoprost, by End Users USD Billion (2025-2030)
  • Table 275. South America Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 276. Brazil Latanoprost, by Type USD Billion (2025-2030)
  • Table 277. Brazil Latanoprost, by Application USD Billion (2025-2030)
  • Table 278. Brazil Latanoprost, by End Users USD Billion (2025-2030)
  • Table 279. Brazil Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 280. Argentina Latanoprost, by Type USD Billion (2025-2030)
  • Table 281. Argentina Latanoprost, by Application USD Billion (2025-2030)
  • Table 282. Argentina Latanoprost, by End Users USD Billion (2025-2030)
  • Table 283. Argentina Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 284. Rest of South America Latanoprost, by Type USD Billion (2025-2030)
  • Table 285. Rest of South America Latanoprost, by Application USD Billion (2025-2030)
  • Table 286. Rest of South America Latanoprost, by End Users USD Billion (2025-2030)
  • Table 287. Rest of South America Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 288. Asia Pacific Latanoprost, by Country USD Billion (2025-2030)
  • Table 289. Asia Pacific Latanoprost, by Type USD Billion (2025-2030)
  • Table 290. Asia Pacific Latanoprost, by Application USD Billion (2025-2030)
  • Table 291. Asia Pacific Latanoprost, by End Users USD Billion (2025-2030)
  • Table 292. Asia Pacific Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 293. China Latanoprost, by Type USD Billion (2025-2030)
  • Table 294. China Latanoprost, by Application USD Billion (2025-2030)
  • Table 295. China Latanoprost, by End Users USD Billion (2025-2030)
  • Table 296. China Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 297. Japan Latanoprost, by Type USD Billion (2025-2030)
  • Table 298. Japan Latanoprost, by Application USD Billion (2025-2030)
  • Table 299. Japan Latanoprost, by End Users USD Billion (2025-2030)
  • Table 300. Japan Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 301. India Latanoprost, by Type USD Billion (2025-2030)
  • Table 302. India Latanoprost, by Application USD Billion (2025-2030)
  • Table 303. India Latanoprost, by End Users USD Billion (2025-2030)
  • Table 304. India Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 305. South Korea Latanoprost, by Type USD Billion (2025-2030)
  • Table 306. South Korea Latanoprost, by Application USD Billion (2025-2030)
  • Table 307. South Korea Latanoprost, by End Users USD Billion (2025-2030)
  • Table 308. South Korea Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 309. Taiwan Latanoprost, by Type USD Billion (2025-2030)
  • Table 310. Taiwan Latanoprost, by Application USD Billion (2025-2030)
  • Table 311. Taiwan Latanoprost, by End Users USD Billion (2025-2030)
  • Table 312. Taiwan Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 313. Australia Latanoprost, by Type USD Billion (2025-2030)
  • Table 314. Australia Latanoprost, by Application USD Billion (2025-2030)
  • Table 315. Australia Latanoprost, by End Users USD Billion (2025-2030)
  • Table 316. Australia Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 317. Rest of Asia-Pacific Latanoprost, by Type USD Billion (2025-2030)
  • Table 318. Rest of Asia-Pacific Latanoprost, by Application USD Billion (2025-2030)
  • Table 319. Rest of Asia-Pacific Latanoprost, by End Users USD Billion (2025-2030)
  • Table 320. Rest of Asia-Pacific Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 321. Europe Latanoprost, by Country USD Billion (2025-2030)
  • Table 322. Europe Latanoprost, by Type USD Billion (2025-2030)
  • Table 323. Europe Latanoprost, by Application USD Billion (2025-2030)
  • Table 324. Europe Latanoprost, by End Users USD Billion (2025-2030)
  • Table 325. Europe Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 326. Germany Latanoprost, by Type USD Billion (2025-2030)
  • Table 327. Germany Latanoprost, by Application USD Billion (2025-2030)
  • Table 328. Germany Latanoprost, by End Users USD Billion (2025-2030)
  • Table 329. Germany Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 330. France Latanoprost, by Type USD Billion (2025-2030)
  • Table 331. France Latanoprost, by Application USD Billion (2025-2030)
  • Table 332. France Latanoprost, by End Users USD Billion (2025-2030)
  • Table 333. France Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 334. Italy Latanoprost, by Type USD Billion (2025-2030)
  • Table 335. Italy Latanoprost, by Application USD Billion (2025-2030)
  • Table 336. Italy Latanoprost, by End Users USD Billion (2025-2030)
  • Table 337. Italy Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 338. United Kingdom Latanoprost, by Type USD Billion (2025-2030)
  • Table 339. United Kingdom Latanoprost, by Application USD Billion (2025-2030)
  • Table 340. United Kingdom Latanoprost, by End Users USD Billion (2025-2030)
  • Table 341. United Kingdom Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 342. Netherlands Latanoprost, by Type USD Billion (2025-2030)
  • Table 343. Netherlands Latanoprost, by Application USD Billion (2025-2030)
  • Table 344. Netherlands Latanoprost, by End Users USD Billion (2025-2030)
  • Table 345. Netherlands Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 346. Rest of Europe Latanoprost, by Type USD Billion (2025-2030)
  • Table 347. Rest of Europe Latanoprost, by Application USD Billion (2025-2030)
  • Table 348. Rest of Europe Latanoprost, by End Users USD Billion (2025-2030)
  • Table 349. Rest of Europe Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 350. MEA Latanoprost, by Country USD Billion (2025-2030)
  • Table 351. MEA Latanoprost, by Type USD Billion (2025-2030)
  • Table 352. MEA Latanoprost, by Application USD Billion (2025-2030)
  • Table 353. MEA Latanoprost, by End Users USD Billion (2025-2030)
  • Table 354. MEA Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 355. Middle East Latanoprost, by Type USD Billion (2025-2030)
  • Table 356. Middle East Latanoprost, by Application USD Billion (2025-2030)
  • Table 357. Middle East Latanoprost, by End Users USD Billion (2025-2030)
  • Table 358. Middle East Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 359. Africa Latanoprost, by Type USD Billion (2025-2030)
  • Table 360. Africa Latanoprost, by Application USD Billion (2025-2030)
  • Table 361. Africa Latanoprost, by End Users USD Billion (2025-2030)
  • Table 362. Africa Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 363. North America Latanoprost, by Country USD Billion (2025-2030)
  • Table 364. North America Latanoprost, by Type USD Billion (2025-2030)
  • Table 365. North America Latanoprost, by Application USD Billion (2025-2030)
  • Table 366. North America Latanoprost, by End Users USD Billion (2025-2030)
  • Table 367. North America Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 368. United States Latanoprost, by Type USD Billion (2025-2030)
  • Table 369. United States Latanoprost, by Application USD Billion (2025-2030)
  • Table 370. United States Latanoprost, by End Users USD Billion (2025-2030)
  • Table 371. United States Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 372. Canada Latanoprost, by Type USD Billion (2025-2030)
  • Table 373. Canada Latanoprost, by Application USD Billion (2025-2030)
  • Table 374. Canada Latanoprost, by End Users USD Billion (2025-2030)
  • Table 375. Canada Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 376. Mexico Latanoprost, by Type USD Billion (2025-2030)
  • Table 377. Mexico Latanoprost, by Application USD Billion (2025-2030)
  • Table 378. Mexico Latanoprost, by End Users USD Billion (2025-2030)
  • Table 379. Mexico Latanoprost, by Bottle Size USD Billion (2025-2030)
  • Table 380. Latanoprost Sales: by Type(K Liters)
  • Table 381. Latanoprost Sales Brand Drug , by Region K Liters (2025-2030)
  • Table 382. Latanoprost Sales Generic Drug , by Region K Liters (2025-2030)
  • Table 383. Latanoprost Sales: by Application(K Liters)
  • Table 384. Latanoprost Sales Open-angle Glaucoma , by Region K Liters (2025-2030)
  • Table 385. Latanoprost Sales Close-angle Glaucoma , by Region K Liters (2025-2030)
  • Table 386. Latanoprost Sales: by End Users(K Liters)
  • Table 387. Latanoprost Sales Pediatrics , by Region K Liters (2025-2030)
  • Table 388. Latanoprost Sales Adults , by Region K Liters (2025-2030)
  • Table 389. Latanoprost Sales Geriatrics , by Region K Liters (2025-2030)
  • Table 390. Latanoprost Sales: by Bottle Size(K Liters)
  • Table 391. Latanoprost Sales 2.5 ml , by Region K Liters (2025-2030)
  • Table 392. Latanoprost Sales 5 ml , by Region K Liters (2025-2030)
  • Table 393. Latanoprost Sales Others , by Region K Liters (2025-2030)
  • Table 394. South America Latanoprost Sales, by Country K Liters (2025-2030)
  • Table 395. South America Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 396. South America Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 397. South America Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 398. South America Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 399. Brazil Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 400. Brazil Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 401. Brazil Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 402. Brazil Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 403. Argentina Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 404. Argentina Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 405. Argentina Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 406. Argentina Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 407. Rest of South America Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 408. Rest of South America Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 409. Rest of South America Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 410. Rest of South America Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 411. Asia Pacific Latanoprost Sales, by Country K Liters (2025-2030)
  • Table 412. Asia Pacific Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 413. Asia Pacific Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 414. Asia Pacific Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 415. Asia Pacific Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 416. China Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 417. China Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 418. China Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 419. China Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 420. Japan Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 421. Japan Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 422. Japan Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 423. Japan Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 424. India Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 425. India Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 426. India Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 427. India Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 428. South Korea Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 429. South Korea Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 430. South Korea Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 431. South Korea Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 432. Taiwan Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 433. Taiwan Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 434. Taiwan Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 435. Taiwan Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 436. Australia Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 437. Australia Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 438. Australia Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 439. Australia Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 440. Rest of Asia-Pacific Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 441. Rest of Asia-Pacific Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 442. Rest of Asia-Pacific Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 443. Rest of Asia-Pacific Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 444. Europe Latanoprost Sales, by Country K Liters (2025-2030)
  • Table 445. Europe Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 446. Europe Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 447. Europe Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 448. Europe Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 449. Germany Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 450. Germany Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 451. Germany Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 452. Germany Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 453. France Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 454. France Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 455. France Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 456. France Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 457. Italy Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 458. Italy Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 459. Italy Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 460. Italy Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 461. United Kingdom Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 462. United Kingdom Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 463. United Kingdom Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 464. United Kingdom Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 465. Netherlands Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 466. Netherlands Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 467. Netherlands Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 468. Netherlands Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 469. Rest of Europe Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 470. Rest of Europe Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 471. Rest of Europe Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 472. Rest of Europe Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 473. MEA Latanoprost Sales, by Country K Liters (2025-2030)
  • Table 474. MEA Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 475. MEA Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 476. MEA Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 477. MEA Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 478. Middle East Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 479. Middle East Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 480. Middle East Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 481. Middle East Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 482. Africa Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 483. Africa Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 484. Africa Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 485. Africa Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 486. North America Latanoprost Sales, by Country K Liters (2025-2030)
  • Table 487. North America Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 488. North America Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 489. North America Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 490. North America Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 491. United States Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 492. United States Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 493. United States Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 494. United States Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 495. Canada Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 496. Canada Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 497. Canada Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 498. Canada Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 499. Mexico Latanoprost Sales, by Type K Liters (2025-2030)
  • Table 500. Mexico Latanoprost Sales, by Application K Liters (2025-2030)
  • Table 501. Mexico Latanoprost Sales, by End Users K Liters (2025-2030)
  • Table 502. Mexico Latanoprost Sales, by Bottle Size K Liters (2025-2030)
  • Table 503. Latanoprost: by Type(USD/Units)
  • Table 504. Research Programs/Design for This Report
  • Table 505. Key Data Information from Secondary Sources
  • Table 506. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Latanoprost: by Type USD Billion (2018-2023)
  • Figure 5. Global Latanoprost: by Application USD Billion (2018-2023)
  • Figure 6. Global Latanoprost: by End Users USD Billion (2018-2023)
  • Figure 7. Global Latanoprost: by Bottle Size USD Billion (2018-2023)
  • Figure 8. South America Latanoprost Share (%), by Country
  • Figure 9. Asia Pacific Latanoprost Share (%), by Country
  • Figure 10. Europe Latanoprost Share (%), by Country
  • Figure 11. MEA Latanoprost Share (%), by Country
  • Figure 12. North America Latanoprost Share (%), by Country
  • Figure 13. Global Latanoprost: by Type K Liters (2018-2023)
  • Figure 14. Global Latanoprost: by Application K Liters (2018-2023)
  • Figure 15. Global Latanoprost: by End Users K Liters (2018-2023)
  • Figure 16. Global Latanoprost: by Bottle Size K Liters (2018-2023)
  • Figure 17. South America Latanoprost Share (%), by Country
  • Figure 18. Asia Pacific Latanoprost Share (%), by Country
  • Figure 19. Europe Latanoprost Share (%), by Country
  • Figure 20. MEA Latanoprost Share (%), by Country
  • Figure 21. North America Latanoprost Share (%), by Country
  • Figure 22. Global Latanoprost: by Type USD/Units (2018-2023)
  • Figure 23. Global Latanoprost share by Players 2023 (%)
  • Figure 24. Global Latanoprost share by Players (Top 3) 2023(%)
  • Figure 25. Global Latanoprost share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer (United States) Revenue: by Geography 2023
  • Figure 29. Aerie Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 30. Aerie Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 31. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 32. Mylan (United States) Revenue: by Geography 2023
  • Figure 33. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Novartis International AG (Switzerland) Revenue: by Geography 2023
  • Figure 35. Teva Pharmaceutical Industries (Israel) Revenue, Net Income and Gross profit
  • Figure 36. Teva Pharmaceutical Industries (Israel) Revenue: by Geography 2023
  • Figure 37. S.C. ROMPHARM COMPANY S.R.L (Romania) Revenue, Net Income and Gross profit
  • Figure 38. S.C. ROMPHARM COMPANY S.R.L (Romania) Revenue: by Geography 2023
  • Figure 39. Apotex (Canada) Revenue, Net Income and Gross profit
  • Figure 40. Apotex (Canada) Revenue: by Geography 2023
  • Figure 41. Sun Pharma (India) Revenue, Net Income and Gross profit
  • Figure 42. Sun Pharma (India) Revenue: by Geography 2023
  • Figure 43. CR Zizhu (China) Revenue, Net Income and Gross profit
  • Figure 44. CR Zizhu (China) Revenue: by Geography 2023
  • Figure 45. Global Latanoprost: by Type USD Billion (2025-2030)
  • Figure 46. Global Latanoprost: by Application USD Billion (2025-2030)
  • Figure 47. Global Latanoprost: by End Users USD Billion (2025-2030)
  • Figure 48. Global Latanoprost: by Bottle Size USD Billion (2025-2030)
  • Figure 49. South America Latanoprost Share (%), by Country
  • Figure 50. Asia Pacific Latanoprost Share (%), by Country
  • Figure 51. Europe Latanoprost Share (%), by Country
  • Figure 52. MEA Latanoprost Share (%), by Country
  • Figure 53. North America Latanoprost Share (%), by Country
  • Figure 54. Global Latanoprost: by Type K Liters (2025-2030)
  • Figure 55. Global Latanoprost: by Application K Liters (2025-2030)
  • Figure 56. Global Latanoprost: by End Users K Liters (2025-2030)
  • Figure 57. Global Latanoprost: by Bottle Size K Liters (2025-2030)
  • Figure 58. South America Latanoprost Share (%), by Country
  • Figure 59. Asia Pacific Latanoprost Share (%), by Country
  • Figure 60. Europe Latanoprost Share (%), by Country
  • Figure 61. MEA Latanoprost Share (%), by Country
  • Figure 62. North America Latanoprost Share (%), by Country
  • Figure 63. Global Latanoprost: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • Aerie Pharmaceuticals (United States)
  • Mylan (United States)
  • Novartis International AG (Switzerland)
  • Teva Pharmaceutical Industries (Israel)
  • S.C. ROMPHARM COMPANY S.R.L (Romania)
  • Apotex (Canada)
  • Sun Pharma (India)
  • CR Zizhu (China)
Additional players considered in the study are as follows:
Laboratoire Riva (Canada) , Taj Pharma (India) , Sandoz (Germany) , Laboratoires Thea (France)
Select User Access Type

Key Highlights of Report


Mar 2024 165 Pages 86 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Latanoprost Market Quantitative research analysis
Global Latanoprost Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Latanoprost market are Pfizer (United States), Aerie Pharmaceuticals (United States), Mylan (United States), Novartis International AG (Switzerland), Teva Pharmaceutical Industries (Israel), S.C. ROMPHARM COMPANY S.R.L (Romania), Apotex (Canada), Sun Pharma (India) and CR Zizhu (China).
In this highly competitive & fast evolving Latanoprost industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Open-angle Glaucoma and Close-angle Glaucoma are the potential customers of Latanoprost industry.
The Global Latanoprost market is expected to see a growth of 2.4% during projected year 2023 to 2030.

Know More About Global Latanoprost Market Report?

Have a Query? Click Here

Other Related Reports

Aspirin Comprehensive Study by Type (99.5% Purity, 99% Purity, Others), Application (Tablets Product, Capsule Product, Others), End-User (Hospitals, Ambulatory Surgical Center (ASC), Others) Players ...
$ 3500
First Aid Comprehensive Study by Type (Adhesive Bandages, Gauses, Disinfectants, Others), Application (Clinic, Hospital, Home Use) Players and Region - Global Market Outlook to 2030
$ 3500
Glucosamine and Chondroitin Sulfate Comprehensive Study by Application (Pharmaceutical, Dietary Supplements (Animal Feed, Nutraceuticals), Cosmetics, Others), Source (Bovine, Swine, Poultry, Shark, S...
$ 3500
Rasagiline Tablet Comprehensive Study by Type (0.5 mg Tablet, 1 mg Tablet, Others), Application (Clinics and Hospital, Households, Caring Center, Others), Distribution Channel (Online Channels, Offli...
$ 3500
Nasal Polyposis Drug Comprehensive Study by Route of Administration (Oral, Nasal, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Drug Class (Cortic...
$ 3650
Lymphoma Drugs Comprehensive Study by Type (Hodgkin Lymphoma (HL) Drugs, Non-Hodgkin Lymphoma (NHL) Drugs), Lymphoma Treatment Drug (Adcetris, Opdivo, Rituxan/MabThera, Imbruvica, Keytruda, Revlimid,...
$ 3450